Literature DB >> 32684706

A management strategy for giant cell tumor of the metacarpal: A single-center series of 11 cases.

Prakash P Kotwal1, Mohammed Tahir Ansari2, Asjad Mahmood2, Vikas Gupta3, Shah Alam Khan2.   

Abstract

BACKGROUND: Primary giant cell tumor (GCT) arising from bones of hand are rare to occur. Metacarpals are often the most common site of involvement among hand bones. There are no uniform guidelines for treatment of GCT involving metacarpals due to lack of relevant literature.
OBJECTIVE: To suggest a management strategy for GCT involving metacarpals.
METHODS: Retrospective review of cases of GCT involving metacarpals over a period of 15 years from 2005 to 2019 managed at department of Orthopaedics, All India Institute of Medical Sciences, New Delhi.
RESULTS: A total of 12 cases of GCT involving metacarpal were included, out of which one was lost to follow-up. Four cases were recurrent, and seven were primary at the time of surgery. All the patients were operated with wide excision of the tumor. In seven patients reconstruction of the metacarpal and MCPJ was done using fibular strut graft and silastic artificial joint, while in two patients, MCPJ arthrodesis was performed using fibula and/or iliac crest bone graft. In another two patients, the MCPJ was reconstructed using reversed vascularised toe transfer. Mean follow up of the patients was 3.22 ± 2.07 years. Mean Quick DASH score at latest follow-up of patients operated with silastic joint reconstruction, reversed vascularised toe transfer and arthrodesis of MCP joints were 30.5 ± 9.5, 25 ± 2.3 and 39.8 ± 3.4 respectively. Local recurrence occurred only in one patient at one year after surgery. All the patients were pain free at latest follow-up with quite functional and cosmetically acceptable hand.
CONCLUSION: Reversed vascularised metatarsal transfer has obtained better functional results compared to reconstruction with fibular grafting and silicone joint replacement but due to technical difficulties, vascularised joint transfer may not be performed in every setting and there is risk of donor site morbidities with this technique. Our strategy for the treatment of GCT involving metacarpal was to do vascularised joint transfer or arthrodesis for border digits and reconstruction with silicone joint for central digits.
© 2020 Delhi Orthopedic Association. All rights reserved.

Entities:  

Keywords:  Benign; Giant cell; Metacarpal; Tumor

Year:  2020        PMID: 32684706      PMCID: PMC7355077          DOI: 10.1016/j.jcot.2020.05.032

Source DB:  PubMed          Journal:  J Clin Orthop Trauma        ISSN: 0976-5662


  18 in total

1.  Primary giant cell tumours of the digital bones of the hand.

Authors:  M Ropars; R Kaila; S R Cannon; T W R Briggs
Journal:  J Hand Surg Eur Vol       Date:  2007-01-12

2.  Vascularised joint transfer in the management of recurrent giant cell tumour of the second metacarpal.

Authors:  P P Kotwal; C Nagaraj; V Gupta
Journal:  J Hand Surg Eur Vol       Date:  2008-06

3.  Recurrent metacarpal giant cell tumour treated by en bloc resection and metatarsal transfer.

Authors:  J Pardo-Montaner; A Pina-Medina; M Barcelo-Alcañiz
Journal:  J Hand Surg Br       Date:  1998-04

4.  Giant cell tumor of the hand: superior results with curettage, cryosurgery, and cementation.

Authors:  J C Wittig; B M Simpson; J Bickels; K L Kellar-Graney; M M Malawer
Journal:  J Hand Surg Am       Date:  2001-05       Impact factor: 2.230

5.  [Case report of a giant cell tumor of the second metacarpal bone and implantation of a cement prosthesis].

Authors:  W R Dingels; H J Rolle
Journal:  Handchirurgie       Date:  1979

Review 6.  Giant-cell tumours of bone of the hand and wrist: a review of imaging findings and differential diagnoses.

Authors:  S L J James; A M Davies
Journal:  Eur Radiol       Date:  2005-05-03       Impact factor: 5.315

7.  Fourteen-year results of a reversed vascularized second metatarsophalangeal joint transfer: a case report.

Authors:  Kohei Kanaya; Takuro Wada; Masamichi Usui; Toshihiko Yamashita
Journal:  J Hand Surg Am       Date:  2005-01       Impact factor: 2.230

8.  Giant cell tumor of the bones of the hand and foot.

Authors:  R Biscaglia; P Bacchini; F Bertoni
Journal:  Cancer       Date:  2000-05-01       Impact factor: 6.860

9.  Reconstruction with fibular autograft and silicone implant arthroplasty after resection of giant-cell tumour of the proximal phalanx: a case report with 18-month follow-up.

Authors:  M T Ansari; P P Kotwal; S Rao
Journal:  Musculoskelet Surg       Date:  2013-02-01

10.  Giant-cell tumors of the bones of the hand.

Authors:  R M Averill; R J Smith; C J Campbell
Journal:  J Hand Surg Am       Date:  1980-01       Impact factor: 2.230

View more
  1 in total

1.  3D-printed personalised prostheses for bone defect repair and reconstruction following resection of metacarpal giant cell tumours.

Authors:  Lin Xu; Hao Qin; Zhilin Cheng; Wen-Bo Jiang; Jia Tan; Xiang Luo; Wenhua Huang
Journal:  Ann Transl Med       Date:  2021-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.